1-9 of 9
Ralph Meyer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Development and Testing of a Lymphoma Clinical Trials Specific Frailty Index: A Secondary Analysis of the LY.12 Clinical Trial

Abi Vijenthira, Xinzhi Li, Michael Crump, Annette E. Hay, Lois E. Shepherd, Ralph Meyer, Marina S. Djurfeldt, Bingshu E. Chen, Anca Prica
Journal: Blood
Blood (2021) 138 (Supplement 1): 4076.
https://doi.org/10.1182/blood-2021-153037
Published: 2021
Journal Articles

Event-Free Survival As a Surrogate for Overall Survival in Relapsed DLBCL after Autologous Transplant: A Subgroup Analysis of LY.12 and Coral

Sarit Assouline, MD, Shen Li, MD, Christian Gisselbrecht, MD, Patrick Fogarty, Annette E. Hay, Eric Van Den Neste, MD, Lois E. Shepherd, Norbert Schmitz, MD, Tara Baetz, Armand Keating, MD, Sue Robinson, MD, Matthew D. Seftel, FRCP,FRCPC,MPH,MD, Caterina Stelitano, Marina S. Djurfeldt, Ralph Meyer, Bingshu E. Chen, Michael Crump, MD FRCPC
Journal: Blood
Blood (2019) 134 (Supplement_1): 768.
https://doi.org/10.1182/blood-2019-124879
Published: 2019
Journal Articles

Comparison of Outcomes By Age of Patients with Limited Stage Hodgkin Lymphoma Treated with ABVD Alone; A Secondary Analysis of the Canadian Cancer Trial Group HD.6 Trial

Laura N Rodriguez-Romo, MD, Ralph Meyer, MDFRCPC, Joseph L Pater, MD, Jonathan Sussman, MD FRCPC, MSc, Siwei Zhang, MSc, Lui Hongbo, MSc, PhD, Jane N. Winter, MD, Te Vuong, MD, Walter Blahey, MD, Liam Mulroy, MD, Lois E. Shepherd, Marina S Djurfeldt, MSc, Bingshu E. Chen, Annette E Hay
Journal: Blood
Blood (2017) 130 (Supplement 1): 4081.
https://doi.org/10.1182/blood.V130.Suppl_1.4081.4081
Published: 2017
Journal Articles

Potential Utility of Event-Free Survival (EFS) As Surrogate Endpoint for Overall Survival (OS) in Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) after Autologous Stem Cell Transplantation (ASCT): A Subgroup Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Randomized Phase III Trial

Shen Li, MD, Annette E Hay, Michael Crump, MD, Peter Anglin, MD FRCPC, MBA, Tara Baetz, Ralph Meyer, MDFRCPC, Armand Keating, MD, Sue Robinson, MD, Matthew Seftel, MRCP, MD MPH, FRCPC, Caterina Stelitano, Marina S Djurfeldt, MSc, Lois E. Shepherd, Bingshu E. Chen, Sarit Assouline, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2015.
https://doi.org/10.1182/blood.V130.Suppl_1.2015.2015
Published: 2017
Journal Articles

Evaluating the Indirect Costs of Care Associated with Salvage Chemotherapy for Relapsed and Refractory Aggressive-Histology Lymphoma: A Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical Trial

Anca Prica, MD FRCP(C), Annette E Hay, Michael Crump, MD, Nicole Mittman, Lois E. Shepherd, Ralph Meyer, MDFRCPC, Kevin Imrie, MD, Nancy A. Risebrough, Marina S Djurfeldt, MSc, Bingshu E. Chen, Matthew Cheung, MD MS, FRCP
Journal: Blood
Blood (2017) 130 (Supplement 1): 4673.
https://doi.org/10.1182/blood.V130.Suppl_1.4673.4673
Published: 2017
Journal Articles

The Use of IVIG for Solid Organ Transplantation: An Evidence Based Practice Guideline

Nadine Shehata, MD, MSC, Heather Ann Hume, MD, Valerie Palda, MD, MSc, Ralph Meyer, MD, Patricia Campbell, MBChB, Peter Nickerson, MD, Tom D Blydt-Hansen, MD, Lori West, MD, PhD, Heather Ross, MD, Steven Martin, MD, Tom Waddell, MD, Carl Cardella, MD, Davi d Anderson, MD, MSc, John Freedman, MD, Kevork Peltekian, MD
Journal: Blood
Blood (2008) 112 (11): 4666.
https://doi.org/10.1182/blood.V112.11.4666.4666
Published: 2008
Journal Articles

The Use of Erythropoietic Agents in Patients with Non-Myeloid Hematological Malignancies.

Nadine Shehata, MD, MSc, Irwin Walker, MD, Ralph Meyer, MD, Adam Haynes, MSc, Kevin Imrie, MD
Journal: Blood
Blood (2006) 108 (11): 3338.
https://doi.org/10.1182/blood.V108.11.3338.3338
Published: 2006
Journal Articles

Maintenance Therapy with Thalidomide/Prednisone Post Autologous Stem-Cell Transplant for Patients with Multiple Myeloma Elevates D-Dimer and Possibly Factor VIII Levels.

Michael J. Kovacs, MD, FRCPC, Judy-Anne W. Chapman, PhD, Lois Shepherd, MD, FRCPC, Ralph Meyer, MD, FRCPC, Michael Keeney, ART, FIMLS, Karen MacKinnon, MLT, Keith Stewart, MD, FRCPC, Nancy Paul, PhD, The NCIC CTG Investigators on MY.10.
Journal: Blood
Blood (2005) 106 (11): 2561.
https://doi.org/10.1182/blood.V106.11.2561.2561
Published: 2005
Journal Articles

The Effect of Prophylactic Administration of Myeloid Growth Factors Following Autologous Stem Cell Transplantation for Patients with Hematological Malignancies: A Systematic Review.

Graeme A.M. Fraser, M.D., Ahmed Al-Sagheir, M.D., Donald M. Arnold, M.D., C. Tom Kouroukis, M.D., Ronan Foley, M.D., Ralph Meyer, M.D.
Journal: Blood
Blood (2004) 104 (11): 2192.
https://doi.org/10.1182/blood.V104.11.2192.2192
Published: 2004